MXC: $0.041

Doctors are very important to MGC Pharmaceuticals, because they are the gateway to our patients.

Our Doctors have the most influence on the integration of Phytocannabinoid therapy into our world’s existing scope of treatments. That’s why MGC Pharma strives to educate doctors about Medical Cannabis and the Endo-Cannabinoid system, in order to facilitate new and innovative solutions for patients that offer relief from many of today’s prevalent diseases.

Doctors' Access

In MGC Pharma’s Doctor access point, doctors can discover information about Medical Cannabis and engage with MGC in order to become authorised prescribers in certain countries. They can also familiarise themselves with MGC’s R&D and clinical pipelines in order to understand the changes that will be coming with the inclusion of Phytocannabinoid medications within the existing treatment spectrum.

Sign up to receive information on how to prescribe Medicinal Cannabis in Australia, Science, Regulation and the industry as a whole.